Agilon Health (NYSE:AGL) Sets New 12-Month Low After Earnings Miss

Key Points

• Agilon Health's shares fell to a new 52-week low of $0.71 after the company reported a quarterly earnings per share (EPS) of ($0.25), missing analysts' expectations by ($0.14).
• The company's revenues decreased by 5.9% compared to the previous year, coming in at $1.39 billion, below the estimated $1.47 billion.
• Recent analyst ratings for Agilon Health include a price target cut by Wells Fargo to $5.00, while other analysts maintained varying targets, leading to a consensus rating of "Hold".

Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s share price hit a new 52-week low on Tuesday after the company announced weaker than expected quarterly earnings. The company traded as low as $0.71 and last traded at $0.89, with a volume of 174932843 shares changing hands. The stock had previously closed at $1.82.

The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health's quarterly revenue was down 5.9% on a year-over-year basis. During the same period in the prior year, the business posted ($0.07) EPS.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Evercore ISI decreased their price objective on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research report on Wednesday, July 9th. Barclays decreased their price target on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating on the stock in a report on Wednesday. Wells Fargo & Company cut their target price on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research report on Tuesday, May 13th. Benchmark lowered their price target on Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research report on Wednesday. Finally, Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $3.25 to $5.00 in a report on Friday, April 25th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat, Agilon Health presently has an average rating of "Hold" and a consensus price target of $4.07.

Institutional Investors Weigh In On Agilon Health

Several institutional investors and hedge funds have recently bought and sold shares of the business. Captrust Financial Advisors lifted its stake in Agilon Health by 10.9% in the fourth quarter. Captrust Financial Advisors now owns 35,485 shares of the company's stock worth $67,000 after acquiring an additional 3,494 shares during the period. Signaturefd LLC increased its position in Agilon Health by 28.3% during the 1st quarter. Signaturefd LLC now owns 18,461 shares of the company's stock valued at $80,000 after purchasing an additional 4,073 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Agilon Health by 2.5% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company's stock worth $393,000 after purchasing an additional 5,107 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of Agilon Health by 5.6% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 105,324 shares of the company's stock worth $256,000 after purchasing an additional 5,627 shares during the period. Finally, State of Wyoming boosted its stake in shares of Agilon Health by 4.9% during the 1st quarter. State of Wyoming now owns 128,509 shares of the company's stock valued at $556,000 after purchasing an additional 6,005 shares in the last quarter.

Agilon Health Trading Down 0.4%

The business's 50 day moving average price is $2.08 and its two-hundred day moving average price is $3.15. The stock has a market cap of $361.33 million, a P/E ratio of -1.13 and a beta of 0.14.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.